$0.02▴ 0.00%
End-of-day close · 2026-08-05
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-11.45MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
75th pctvs its own history
Rich
Its valuation sits in the richer end of its own recent range.
Revenue growth
+14.3%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Silexion Therapeutics Corp is pre-profit. It is still burning cash while pre-profit. Revenue is growing at a steady pace. Its valuation sits in the richer end of its own recent range.
Key numbers
Valuation
EPS (TTM)$8.31
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-8746.2%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$117000.00
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.